Connect Sign In
ARUP Laboratories announced that it is making a second COVID-19 IgG antibody test available nationwide.
Medical laboratory scientists who work in hospital labs and in national reference laboratories such as ARUP are the inconspicuous, less visible participants in helping to diagnose patients.
Hydroxychloroquine interferes with a virus’s ability to replicate, but that mechanism is unproven in patients with COVID-19. Small inpatient studies of the drug have thus far not been promising.
ARUP Laboratories will play a key role in a CDC-funded project that aims to reduce the risk of COVID-19 infection in hospital emergency department workers nationwide.
The David Eccles School of Business at the U and University of Utah Health announce the start of Utah HERO, an undertaking that will begin with testing 10,000 Utahns across four counties.
In the six weeks since ARUP became the first clinical laboratory in Utah and one of the first in the U.S. to offer COVID-19 diagnostic testing, ARUP has performed more than 40,000 tests in Utah alone.
Julio Delgado, MD, MS, ARUP chief medical officer and director of laboratories, is the featured guest on the newest episode of “Silicon Slopes Live.” He discusses COVID-19 antibody testing.
Much of the attention surrounding COVID-19 laboratory testing has focused on two primary areas: viral detection to establish diagnosis and antibody testing to assess previous exposure.
Clinicians and patients always want to know they can trust the accuracy of lab test results. This has never been more true than it is now, given the attention on COVID-19 testing.
ARUP announced it will begin rolling out COVID-19 antibody testing nationwide by the end of this week. IgG antibody tests help detect antibodies to SARS-CoV-2, the virus that causes COVID-19.
